regulatoryservice.pl

What It Is

TopPharm Consulting is a regulatory affairs consulting provider based in Warsaw, Poland, focusing on compliance for pharmaceuticals, medical devices, food supplements, and cosmetics in the Polish and EU markets. Based on the collected content, it is not a SaaS platform in the conventional sense, but rather a professional services firm centered on expert consulting and the execution of registration affairs.

Core Capabilities

Its core value lies in marketing authorization applications and authorization maintenance for pharmaceuticals. Services cover Polish national procedures, EU MRP and DCP procedures, and also mention experience with the centralized procedure. It also supports variations, renewals, notifications, pharmacovigilance, preparation and publishing of eCTD and NeeS dossiers, PIL readability testing, and the preparation and translation of SmPC/PIL/labels and Braille. The company emphasizes that its team members have worked at Polish regulatory authorities and consulting firms, and are familiar with local regulations, interpretation of EU guidelines, and how regulators operate in practice. It can help prepare scientific documentation, communicate with competent authorities, and respond to formal or scientific question lists/deficiency comments.

Pricing and Productization

The website does not disclose packages, billing models, project quotes, free trials, or online subscription information. Therefore, from a SaaS or enterprise software evaluation perspective, its level of productization, standardization, and self-service availability is unclear. It is better viewed as a project-based regulatory consulting supplier rather than software that can be purchased and deployed directly.

Pros and Cons

Its strengths lie in solid local regulatory experience in Poland and a service scope that covers multiple key stages of the pharmaceutical registration lifecycle, making it especially suitable for overseas pharmaceutical companies lacking local regulatory expertise. The downside is that publicly available information is limited: there are no details on security or compliance certifications, data processing mechanisms, third-party system integrations, APIs, team permissions, or delivery workflows, and there is also no transparency around client cases or pricing.

Who It’s For and Access From China

It is suitable for pharmaceutical companies planning to enter the Polish or EU market and needing support with drug registration, eCTD dossiers, PIL testing, marketing authorization maintenance, or regulatory communications. The collected text does not make it possible to determine access conditions from China, so actual website connectivity should be tested. Payment methods are also not disclosed. Chinese companies that place greater importance on Chinese-language communication and local payment options may also want to compare domestic pharmaceutical registration consultancies, CRO regulatory teams, or international consulting firms with EU registration experience.